113 related articles for article (PubMed ID: 37103437)
1. Bladder and Kidney Cancer Diagnosis and Survival Increase With Medicare Eligibility at Age 65.
Shu TD; Prunty MC; Pominville R; Omil-Lima D; Castro Bigalli AA; Kutikov A; Bukavina L; Calaway AC; Markt SC
Urol Pract; 2023 Jan; 10(1):59-65. PubMed ID: 37103437
[TBL] [Abstract][Full Text] [Related]
2. Cancer diagnoses and survival rise as 65-year-olds become Medicare-eligible.
Patel DC; He H; Berry MF; Yang CJ; Trope WL; Wang Y; Lui NS; Liou DZ; Backhus LM; Shrager JB
Cancer; 2021 Jul; 127(13):2302-2310. PubMed ID: 33778953
[TBL] [Abstract][Full Text] [Related]
3. Does the Diagnosis of Bladder Cancer Lead to Higher Rates of Smoking Cessation? Findings from the Medicare Health Outcomes Survey.
Winters BR; Wen L; Holt SK; Dash A; Gore JL; Schade GR; Wright JL
J Urol; 2019 Aug; 202(2):241-246. PubMed ID: 30835630
[TBL] [Abstract][Full Text] [Related]
4. New Mental Health Diagnosis as a Prognostic Factor for Muscle-Invasive Bladder Cancer.
Ayyash O; Yabes J; Hugar L; Maganty A; Williams SB; Wulff-Burchfield E; Davies B; Jacobs B
Clin Genitourin Cancer; 2023 Apr; 21(2):e1-e8. PubMed ID: 36446679
[TBL] [Abstract][Full Text] [Related]
5. Impact of psychiatric illness on decreased survival in elderly patients with bladder cancer in the United States.
Jazzar U; Yong S; Klaassen Z; Huo J; Hughes BD; Esparza E; Mehta HB; Kim SP; Tyler DS; Freedland SJ; Kamat AM; Wolf DV; Williams SB
Cancer; 2018 Aug; 124(15):3127-3135. PubMed ID: 29660813
[TBL] [Abstract][Full Text] [Related]
6. Urinary tract infection-like symptom is associated with worse bladder cancer outcomes in the Medicare population: Implications for sex disparities.
Richards KA; Ham S; Cohn JA; Steinberg GD
Int J Urol; 2016 Jan; 23(1):42-7. PubMed ID: 26443388
[TBL] [Abstract][Full Text] [Related]
7. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.
Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB
Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998
[TBL] [Abstract][Full Text] [Related]
8. Management of Small Kidney Cancers in the New Millennium: Contemporary Trends and Outcomes in a Population-Based Cohort.
Huang WC; Atoria CL; Bjurlin M; Pinheiro LC; Russo P; Lowrance WT; Elkin EB
JAMA Surg; 2015 Jul; 150(7):664-72. PubMed ID: 26017316
[TBL] [Abstract][Full Text] [Related]
9. Provider treatment intensity and outcomes for patients with early-stage bladder cancer.
Hollenbeck BK; Ye Z; Dunn RL; Montie JE; Birkmeyer JD
J Natl Cancer Inst; 2009 Apr; 101(8):571-80. PubMed ID: 19351919
[TBL] [Abstract][Full Text] [Related]
10. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis.
Canter D; Egleston B; Wong YN; Smaldone MC; Simhan J; Greenberg RE; Uzzo RG; Kutikov A
Urol Oncol; 2013 Aug; 31(6):866-70. PubMed ID: 21906968
[TBL] [Abstract][Full Text] [Related]
11. The Cost to Medicare of Bladder Cancer Care.
Sloan FA; Yashkin AP; Akushevich I; Inman BA
Eur Urol Oncol; 2020 Aug; 3(4):515-522. PubMed ID: 31412015
[TBL] [Abstract][Full Text] [Related]
12. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Klint A; Bray F; Storm HH
Acta Oncol; 2010 Jun; 49(5):655-64. PubMed ID: 20156116
[TBL] [Abstract][Full Text] [Related]
13. Trends in PET Scan Usage for Imaging of Patients Diagnosed With Nonmetastatic Urologic Cancer.
Adejoro O; Alishahi A; Soubra A; Konety B
Clin Genitourin Cancer; 2016 Feb; 14(1):38-47.e1. PubMed ID: 26525859
[TBL] [Abstract][Full Text] [Related]
14. Persistent muscle-invasive bladder cancer after neoadjuvant chemotherapy: an analysis of Surveillance, Epidemiology and End Results-Medicare data.
Lane G; Risk M; Fan Y; Krishna S; Konety B
BJU Int; 2019 May; 123(5):818-825. PubMed ID: 30126053
[TBL] [Abstract][Full Text] [Related]
15. The Prevalence and Impact of Urinary Marker Testing in Patients with Bladder Cancer.
Narayan VM; Adejoro O; Schwartz I; Ziegelmann M; Elliott S; Konety BR
J Urol; 2018 Jan; 199(1):74-80. PubMed ID: 28859894
[TBL] [Abstract][Full Text] [Related]
16. Impact of Alzheimer's disease and related dementia diagnosis following treatment for bladder cancer.
Jazzar U; Shan Y; Klaassen Z; Freedland SJ; Kamat AM; Raji MA; Masel T; Tyler DS; Baillargeon J; Kuo YF; Mehta HB; Bergerot CD; Williams SB
J Geriatr Oncol; 2020 Sep; 11(7):1118-1124. PubMed ID: 32354675
[TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
[TBL] [Abstract][Full Text] [Related]
18. Carcinomas of the Renal Pelvis, Ureters, and Urinary Bladder Share a Carcinogenic Field as Revealed in Epidemiological Analysis of Tumor Registry Data.
Aragon-Ching JB; Nizam A; Henson DE
Clin Genitourin Cancer; 2019 Dec; 17(6):436-442. PubMed ID: 31445851
[TBL] [Abstract][Full Text] [Related]
19. Effect of perioperative blood transfusion on mortality for major urologic malignancies.
Soubra A; Zabell JR; Adejoro O; Konety BR
Clin Genitourin Cancer; 2015 Jun; 13(3):e173-81. PubMed ID: 25600760
[TBL] [Abstract][Full Text] [Related]
20. Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
Adejoro O; Alishahi A; Konety B
Urology; 2016 Nov; 97():130-137.e1. PubMed ID: 27397095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
